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SCID mouse spleen does not support scrapie agent replication
K. I. O ' R o u r k e , 1. T. P. Huff, 1 C. W . Leathers, 2 M . M . R o b i n s o n I and J. R. G o r h a m 1
1 United States Department o f Agriculture, Agricultural Research Service, Animal Disease Research Unit, Pullman,
Washington 99164-7030 and 2 Washington Animal Disease Diagnostic Laboratory, Washington State University,
Pullman, Washington 99164-7034, U.S.A.

BALB/c and severe combined immunodeficiency (SCID)
mice were inoculated intracerebrally or intraperitoneally
with scrapie agent strain ME7 to examine the role of
functional lymphocytes and follicular dendritic cells in
splenic infectivity and PrP sc accumulation. Intracerebrally inoculated BALB/c and SCID mice developed
the clinical signs and microscopic lesions characteristic

of scrapie. Spleens from terminally affected BALB/c
mice contained PrP s° which was detectable by immunoblot analysis; SCID mouse spleens did not contain
detectable PrP so. SCID mouse spleens collected during
the first 90 days after intraperitoneal infection contained
neither infectivity nor PrP s°.

Sheep scrapie is the archetype of a heterogeneous group
of rare transmissible spongiform encephalopathies
(TSEs) occurring naturally in humans, cattle, mink, cats
and captive deer (Hartsough & Burger, 1965; Williams &
Young, 1980; Wells et al., 1987; Leggett et al., 1990;
Brown & Gajdusek, 1991). The histopathological lesions
of TSEs are restricted to the nervous system (Chandler,
1969). However, immunohistochemical and biochemical
analyses detect a host cellular membrane glycoprotein,
the prion protein (PrP c) (Prusiner, 1982; Oesch et al.,
1985; Basler et al., 1986), that accumulates in lymphoid
and nervous tissues as a relatively protease-resistant
isoform [PrP s~ in scrapie-infected animals and PrP cJD in
Creutzfeldt-Jakob disease (CJD)-infected animals] (Merz
et al., 1987; Doi et al., 1988; Farquhar et al., 1989;
Kitamoto et al., 1989; Race et al., 1992). PrP sc is tightly
associated with infectivity and may either contain or be
the infectious agent itself (Diringer et al., 1983 ; McKinley
et al., 1983; Merz et al., 1984, 1987). Infectivity and PrP sc
accumulation in the spleen are detectable within 2 weeks
of experimental infection in rodents and persist throughout the incubation period (Eklund et al., 1967; Race &
Ernst, 1992). Scrapie infectivity in the spleen is associated
with post-mitotic non-lymphoid (stromal) cells and is
unaffected by thymectomy (McFarlin et al., 1971;
Worthington & Clark, 1971 ; Clarke & Kimberlin, 1984;
Robinson & Gorham, 1990). PrP c in normal mouse
spleens and prpSc/prP cJD accumulation in infected
mouse spleens is restricted to cells with the morphological
characteristics and antigen-trapping capacity of follicular
dendritic cells (FDCs) (Kitamoto et al., 1991; McBride et
al., 1992). In spite of these similarities, the splenic

replication phase is not obligatory in all rodent TSE
models. Prion mRNA is detectable in mouse spleens by
Northern blot analysis (Caughey et al., 1988) and PrP c is
detectable by immunoblot and immunofluorescence
analysis of hamster leukocytes and spleens (Bendheim et
al., 1992).
Severe combined immunodeficiency (SCID) mice,
which lack functional FDCs secondary to the absence of
lymphocytes (Kapasi et al., 1993), do not develop clinical
signs of CJD or accumulation of splenic PrP eJD following
intraperitoneal (i.p.) inoculation (Kitamoto et al., 1991),
although CJD is readily transmitted to SCID mice by the
intracerebral (i.c.) route. To extend this observation, we
have examined splenic infectivity and PrP s° accumulation
in SCID mice inoculated with scrapie agent strain ME7.
Homozygous C.B.-17-SCID/SCID female mice, 3
weeks of age, were obtained from Taconic Laboratories
and normal 3-week-old female BALB/c mice were
obtained from B&K Universal. All mice were housed in
groups of two to four animals in microisolator cages and
given autoclaved food and water. Scrapie agent strain
ME7 was obtained as whole frozen brains from terminally infected C57BL mice. A 10 % (w/v) brain suspension
was prepared using sterile Tris-buffered saline (TBS;
0'05 M-Tris-HC1 pH 7'8, 0.1 M-NaC1) in a sterile glass
Dounce homogenizer and frozen at - 2 0 °C until
required. Mice were inoculated by the i.e. route with
30 gl or by the i.p. route with 100 gl of freshly thawed
10 % brain homogenate or with dilutions made in sterile
TBS. Controls included untreated mice and mice inoculated with similar volumes of a 10% homogenate of
uninfected C57BL brain or with TBS alone. Mice were
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Table 1. Titration of ME7 in B A L B / c and SCID mice
Dilution of
whole ME7
brain (log10)
1
-2
-3
-4
-5
-6
-7
-8

Animals affected/number inoculated
[incubation range (days)]
BALB/c
3/3 (146-147)
3/3 (161 180)
4/4 (161-182)
4/4(171 196)
4/4(189 198)
3/3 (243)
4/4 (252)
0/4t

SCID
2/2
3/3
2/2
3/3
3/3

(157)
(176)
(176~179)
(184)
(198)
~D*
ND
ND

* ND, Not done.
t Animals euthanized at 426 days p.i.

Table 2. Infectivity bioassay of spleens from i.p.
inoculated B A L B / c and SCID mice
Animals affected/number inoculated
[incubation range (days)]
Time p.i.
(days)

BALB/c donor

SCID donor

30
60
90

16/16 (167 196)
15"/15 (t64-174)
16/16 (174~20l)

0/16
0/16
0/16

* Excludes one mouse which died within 24 h of inoculation.

observed daily for clinical signs (ruffled fur, lethargy,
ataxia) and euthanized either when clearly moribund or
3 weeks after lethargy was first noted. Incubation times
are reported as days from inoculation to euthanasia or
death. The i.c. infectious titre of the inoculum was
109LDs0/ml (Reed & Muench, 1938; Eklund et al.,
1967). Inoculation (i.c.) of SCID mice with the five
lowest dilutions of the inoculum resulted in incubation
periods (Table 1) similar to those observed in BALB/c
mice. Histopathological examination of the brains of
representative affected BALB/c and SCID mice showed
focal spongiosis, astrocytosis and rare intraneuronal
vacuolation (not shown).
Infectivity in the spleens of i.p.-inoculated SCID and
BALB/c mice was determined at 30, 60 and 90 days postinoculation (p.i.). Spleens were collected from individual
ME7-infected BALB/c or SCID mice and from uninfected control mice. All mice were clinically normal when
tissues were collected. Homogenates (10% w/v) were
prepared with sterile TBS in disposable tissue homogenizers, clarified at 228g for 10 rain at 4 °C, and the
supernatants were kept at - 2 0 °C until used. Freshly
thawed suspensions were briefly clarified at 11000 g at
4 °C and bioassayed by i.c. inoculation in groups of four
weanling BALB/c mice per donor spleen. Bioassay
recipient mice were observed daily beginning at 112 days
p.i. for clinical signs of scrapie and surviving animals
were observed for 360 days. Tissues from representative

animals were examined for lesions to confirm the clinical
diagnosis.
Infectivity was detectable in all spleens collected from
ME7-inoculated BALB/c mice. Mean incubation times
for recipients of spleens collected at 30, 60 and 90 days
p.i. were 187, 168 and 184 days respectively (Table 2),
consistent with the observation that splenic infectivity
levels reach a plateau within 2 months following
subcutaneous (Eklund et al., 1967) or i.c. inoculation
(Race & Ernst, 1992). Recipients of inocula from the
spleens of ME7-inoculated SCID mice were clinically
normal throughout the 360 day observation period.
Recipients of inocula from the spleens of uninoculated
BALB/c and SCID mice also remained clinically normal.
These observations demonstrate that scrapie infectivity,
as defined by mouse subinoculation, was not detectable
in the spleens of scrapie-inoculated SCID mice during
the first 90 days p.i.
PrP s° accumulation was monitored by immunoblot
analysis of tissues using the procedure described by Race
& Ernst (1992) with slight modifications. Brains and
spleens were collected from i.c. inoculated mice when
they were terminally affected and from clinically normal,
i.p. inoculated mice at 60 days p.i. Brains from individual
mice or 200 to 250 mg aliquots of spleens from groups of
three mice were prepared as 10 % (w/v) homogenates in
sterile 0.01 M-Tris-HCI pH 7.5, 0.005M-MgC12 using
disposable homogenizers, digested with DNase (final
concentration 1 U/ml) for 1 h at 37 °C, and kept at
- 2 0 °C until assayed. Samples were adjusted to 10%
Sarkosyl, clarified at 10000g for 30 min at 20 °C and
pelleted at 215000g for 2 h at 4°C. Each pellet was
resuspended in 1 ml of 0.01 M-Tris-HC1 pH 7.5 and
incubated with proteinase K (10 lag per g starting tissue)
for 30 rain at 37 °C. The suspension was adjusted to
5 mM-PMSF and centrifuged at 212000 g for 1 h at 4 °C.
Pellets were boiled in SDS-PAGE sample buffer (final
SDS concentration 5 %) and stored at - 2 0 °C until used
for Western immunoblots. PrP s° preparations (representing 1/2 spleen or 1/4 brain per lane) were electrophoresed on 12% polyacrylamide gels (Pharmacia
PhastSystem), transferred to PVDF membranes
(Immobilon-P, Millipore) and probed with anti-PrP or
control rabbit serum. Anti-PrP serum was prepared by
inoculation of rabbits with the pentadecapeptide
G Q G G G T H N Q W N K P S K (Shinagawa et al., 1986)
synthesized as a multimeric macromolecule on a heptalysine backbone (serum R2843) (Tam, 1988) or covalently coupled to keyhole limpet haemocyanin (serum
R27) (Wiley et al., 1987; Race et al., 1992). Bound rabbit
antibody was detected with goat anti-rabbit IgG conjugated to horseradish peroxidase followed by incubation
with a chemiluminescent substrate (Amersham) diluted
1:2 in distilled water. Membranes were exposed to ECL
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Fig. 1. Immunoblots of PrP s~ preparations from SCID (lane 1) or
BALB/c (lane 2) mouse spleen collected 60 days after i.p. inoculation
with scrapie agent ME7. Brain (lane 4) or spleen (lane 5) from clinically
affected i.c. inoculated SCID mouse, or control brain from an
uninoculated BALB/c mouse (lane 3) was probed with rabbit anti-PrP
peptide serum (R27) as described in text.

Hyperfilm (Amersham) for intervals varying from 5 to
60 s. Both antisera gave comparable staining patterns,
although R27 was 50- to 100-fold more sensitive.
PrP s° was detected in the brain but not the spleen of
terminally affected, i.c. inoculated SCID mice (Fig. 1)
and in both the brain and spleen of i.c. inoculated
BALB/c mice. PrP s° was detected in BALB/c mouse
spleen but not in SCID mouse spleen collected 60 days
after i.p. inoculation. These findings are consistent with
the observation that SCID mouse spleen does not
accumulate PrP cJD following either i.c. or i.p. inoculation
(Kitamoto et al., 1991). In that study, PrP cJD was
undetectable in the spleen of a SCID mouse collected 500
days after i.p. inoculation.
In this study, we have demonstrated that the scrapie
agent does not replicate in the spleens of SCID mice.
Furthermore, PrP s~ does not accumulate in SCID mouse
spleen following i.p. or i.c. inoculation with the scrapie
agent. Failure of SCID mouse spleen to accumulate
PrP sc or to harbour infectivity may be due to the
lymphocyte deficiency, the failure of FDCs to mature, or
to other less well characterized defects in SCID mice.
Immunohistochemical evidence for PrP c and prpSc/
PrP cJD in FDCs is consistent with early experiments
using cyclophosphamide-treated mice, which suggested
that the tissue-associated non-mitotic cells (Worthington
& Clark, 1971), rather than the circulating lymphocytes,
are the site of agent replication.
The association of the scrapie agent with antigentrapping cells such as FDCs is of interest because the
agent may replicate in that cell type or it may accumulate
there after replication in other tissues and transport via
the peripheral circulation (Tenner-Racz et al., 1985;
Mori et al., 1991). Pre-clinical diagnostic testing of sheep
by identification of PrP sc in lymphoid tissue has been
proposed (Ikegami et al., 1991; Race et al., 1992;
Onodera et al., 1993). The feasibility of such testing
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increases significantly if a circulating cell type containing
infectivity or PrP s~ can be identified. Further discrimination between endogenous and exogenous sources of
the FDC-associated scrapie agent will be critical to our
understanding of the extraneural pathogenesis of the
TSEs.
The authors thank Laurel Mickelsen and Sue Pritchard for technical
assistance, Alberta Brassfield for helpful discussions, Julie Kooch for
assistance with manuscript preparation and Dr William Davis for
critical review of the manuscript. Dr Richard Race provided antiserum
R27 and helpful advice on immunoblots. ME7 was kindly provided by
the AFRC Neuropathogenesis Unit, Edinburgh, U.K. Mice were
maintained by the personnel of the WSU Laboratory Animal Resource
Center in accordance with the Public Health Service Policy on Humane
Care and Use of Laboratory Animals as specified in the Health
Research and Extension Act of 1985. Product names are necessary to
report factually on available data; however the USDA neither
guarantees nor warrants the standard of the product, and the use of the
name by USDA implies no approval of the product to the exclusion of
others that may also be suitable.
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